1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires John Welsh to Expand Industrials Investment Banking Practice

Our Firm

June 25, 2019

Guggenheim Securities Hires John Welsh to Expand Industrials Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that John Welsh will join the firm as a Senior Managing Director in the Industrials Investment Banking Group. Mr. Welsh will commence work at Guggenheim in September.

Mr. Welsh brings more than 20 years of investment banking experience to Guggenheim. He will join most recently from Barclays, where for the past five years he was Co-Head of the Global Industrials Group. Prior to joining Barclays in 2008, Mr. Welsh was at Lehman Brothers for 10 years.

We are pleased to welcome John to Guggenheim,” said Mark Van Lith, Co-CEO of Guggenheim Securities. “John possesses deep sector knowledge and is a trusted adviser, as evidenced by his long-standing client relationships. We look forward to his leadership and contributions to our clients as we build upon our successful industrials business and the firm generally.”

Mr. Welsh received his B.S. from Indiana University. He will be based in Guggenheim’s New York office.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, San Francisco, and Houston. For more information, please contact us at GSinfo@GuggenheimPartners.com or 212.518.9200.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $265 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,400 professionals based in offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.


Media Contact

Steven Lee
Guggenheim Partners
212.293.2811
Steven.Lee@GuggenheimPartners.com

 

1Assets under management are as of 3.31.2019 and include consulting services for clients whose assets are valued at approximately $60bn.



November 09, 2020

Guggenheim Securities Hires David Levin to Expand Equity Capital Markets

NEW YORK, NY –  Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.

Read More

October 22, 2020

Guggenheim Securities Hires Joe Niemiec to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.

Read More

October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.